PDCD1 and cancer: Among others, especially the potent checkpoint inhibition with anti-PD1 humanized antibodies has been tested in HIS mice bearing various types of tumors (8, 9, 11), highlighting the value of PDX engrafted HIS models for cancer immunotherapies.